CN104474202B - A kind of pharmaceutical composition for the treatment of anorexia - Google Patents
A kind of pharmaceutical composition for the treatment of anorexia Download PDFInfo
- Publication number
- CN104474202B CN104474202B CN201410728850.3A CN201410728850A CN104474202B CN 104474202 B CN104474202 B CN 104474202B CN 201410728850 A CN201410728850 A CN 201410728850A CN 104474202 B CN104474202 B CN 104474202B
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- anorexia
- spleen
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000022531 anorexia Diseases 0.000 title claims abstract description 41
- 206010061428 decreased appetite Diseases 0.000 title claims abstract description 41
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 40
- 230000007812 deficiency Effects 0.000 claims abstract description 21
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 16
- 244000268590 Euryale ferox Species 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 241001061264 Astragalus Species 0.000 claims abstract description 15
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 15
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 15
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 15
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 15
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 15
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 15
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 15
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 15
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 15
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 241000893536 Epimedium Species 0.000 claims abstract description 15
- 235000006533 astragalus Nutrition 0.000 claims abstract description 15
- 235000018905 epimedium Nutrition 0.000 claims abstract description 15
- 210000004233 talus Anatomy 0.000 claims abstract description 15
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 240000007185 Albizia julibrissin Species 0.000 claims abstract description 10
- 235000011468 Albizia julibrissin Nutrition 0.000 claims abstract description 10
- 241000207901 Cuscuta Species 0.000 claims abstract description 7
- 241000132012 Atractylodes Species 0.000 claims abstract description 6
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 5
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 241000092665 Atractylodes macrocephala Species 0.000 claims description 11
- 239000006187 pill Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000006188 syrup Substances 0.000 claims description 9
- 235000020357 syrup Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 241000208671 Campanulaceae Species 0.000 claims description 3
- 235000008504 concentrate Nutrition 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 208000024891 symptom Diseases 0.000 abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 12
- 241000411851 herbal medicine Species 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 36
- 210000002784 stomach Anatomy 0.000 description 17
- 206010012735 Diarrhoea Diseases 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 13
- 241001092040 Crataegus Species 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 240000007371 Cuscuta campestris Species 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 241000703121 Campanula rotundifolia Species 0.000 description 8
- 230000036528 appetite Effects 0.000 description 7
- 235000019789 appetite Nutrition 0.000 description 7
- 230000037406 food intake Effects 0.000 description 7
- 235000012631 food intake Nutrition 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- 241000220433 Albizia Species 0.000 description 5
- 235000011438 Albizia odoratissima Nutrition 0.000 description 5
- 230000004596 appetite loss Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 235000021266 loss of appetite Nutrition 0.000 description 5
- 208000019017 loss of appetite Diseases 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000721662 Juniperus Species 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000005686 eating Nutrition 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 201000005630 leukorrhea Diseases 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 235000006751 Platycodon Nutrition 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229930189914 platycodon Natural products 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021113 Hypothermia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- 208000023505 abnormal feces Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000006191 orally-disintegrating tablet Substances 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医药技术领域,具体涉及一种治疗厌食的药物组合物。所述药物组合物包括如下组分:白术,淮山药,陈皮,淫羊藿,山楂,黄芪,芡实,菟丝子,合欢花,桔梗。本发明药物组合物均为中草药,其制备工艺成熟、原料易得,对于各类常见厌食病症特别是小儿脾胃气虚型厌食症疗效确切,标本兼治,副作用小,治疗后无复发,能够有效治愈厌食症患者。The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating anorexia. The pharmaceutical composition comprises the following components: Atractylodes Rhizoma Atractylodes Rhizome, Chinese Yam, Tangerine Peel, Epimedium, Hawthorn, Astragalus, Gorgon, Cuscuta, Albizia Julibrissin, and Platycodon grandiflorum. The pharmaceutical composition of the present invention is a Chinese herbal medicine, its preparation process is mature, and its raw materials are easy to obtain. It has definite curative effect on various common anorexia diseases, especially anorexia of spleen-stomach-qi deficiency type in children, treats both symptoms and root causes, has little side effects, and can effectively cure anorexia without recurrence after treatment. disease patients.
Description
技术领域technical field
本发明属于医药技术领域,具体涉及一种治疗厌食的药物组合物。The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for treating anorexia.
背景技术Background technique
厌食是指个体长期食欲减退或食欲缺乏为主的症状。厌食患者往往一听到吃饭就恶心、呕吐,总说自己不饿。患者在发病早期,仅有体重减轻的现象,仍能正常工作学习。由于见食不贪,食欲不振,甚则拒食、体重持续下降,严重者伴有营养缺乏,经常出现头晕、头昏、眼花低血糖等反应,稍活动就出汗,毛发脱落、浮肿、低血压、低体温、心动过缓,甚至水电解质和酸硷平衡紊乱。同时患者由于长期刻意挖制食欲不吃饱,消化液分泌减少,引起食量进一步减少。Anorexia refers to the symptoms of long-term loss of appetite or lack of appetite. Anorexia patients often feel nauseous and vomit as soon as they hear about eating, and always say that they are not hungry. In the early stage of the disease, the patient only loses weight and can still work and study normally. Due to not being greedy for food, loss of appetite, or even refusal to eat, and continuous weight loss. In severe cases, accompanied by nutritional deficiencies, dizziness, dizziness, dizziness, hypoglycemia and other reactions often occur, sweating after a little activity, hair loss, edema, hypotension , hypothermia, bradycardia, and even water electrolyte and acid-base balance disorders. At the same time, due to the long-term deliberate suppression of appetite, the patient does not eat enough, and the secretion of digestive juice decreases, causing further reduction in food intake.
患病儿童如得不到及时有效的治疗,可导致营养不良,并发维生素D缺乏性佝偻病、反复呼呼吸道感染等疾病。西医药物治疗多为纠正水电解质的平衡,常采用口服、静点等方式补充消化酶,微量元素,抗生素等化学合成类药物,副作用大,病人依从性差。中医治疗厌食有着丰富的经验,辨证辨病在脾或在胃。在胃者,以胃阴不足为主,证见厌食而口干多饮,大便干结,舌红少津。在脾者,以脾运失健为主,证见厌食,面色少华,腹胀便溏,舌淡苔白。总的治疗原则为健运脾气、养阴益胃,运用中药组方,辩证施治,疗效确切,副作用小,所以研究行之有效的治疗厌食症的中药组合物十分必要。If sick children do not receive timely and effective treatment, they may suffer from malnutrition, vitamin D deficiency rickets, recurrent respiratory tract infection and other diseases. Most of the Western medicine treatment is to correct the balance of water and electrolytes. Oral administration and intravenous injection are often used to supplement digestive enzymes, trace elements, antibiotics and other chemically synthesized drugs, which have large side effects and poor patient compliance. Traditional Chinese medicine has rich experience in the treatment of anorexia, and the syndrome differentiation lies in the spleen or stomach. In the stomach, the deficiency of stomach yin is the main symptom, with symptoms of anorexia, dry mouth, polydipsia, dry stool, red tongue and little fluid. In the case of the spleen, the spleen is mainly impaired, and the symptoms include anorexia, pale complexion, abdominal distension and loose stools, pale tongue with white coating. The general treatment principle is to invigorate the spleen, nourish the yin and benefit the stomach. Using traditional Chinese medicine prescriptions and dialectical treatment, the curative effect is definite and the side effects are small. Therefore, it is very necessary to study effective Chinese medicine compositions for the treatment of anorexia.
发明内容Contents of the invention
本发明提供了一种治疗厌食的新的药物组合物,该药物组合物起效快,疗效好,毒副作用小,它由以下原料制得:白术,淮山药,陈皮,淫羊藿,山楂,黄芪,芡实,菟丝子,合欢花,桔梗。The invention provides a new pharmaceutical composition for treating anorexia. The pharmaceutical composition has fast onset of action, good curative effect and less toxic and side effects. Astragalus, Gorgon, Dodder, Albizia, Bellflower.
本发明所述药物组合物中,所述白术,苦、甘,温。归脾、胃经。健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。In the pharmaceutical composition of the present invention, the Atractylodes Rhizome is bitter, sweet and warm. Return spleen, stomach warp. Invigorating the spleen and replenishing qi, drying dampness and diuresis, antiperspirant, antiabortive. For insufficiency of the spleen, lack of food, abdominal distension and diarrhea, dizziness and palpitation due to phlegm and retention, edema, spontaneous sweating, restless fetal movement. Tubaizhu strengthens the spleen, harmonizes the stomach and relieves miscarriage. For insufficiency of the spleen, lack of food, diarrhea and loose stool, restless fetal movement.
淮山药,甘,平。归脾、肺、肾经。补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。麸炒山药补脾健胃。用于脾虚食少,泄泻便溏,白带过多。Chinese yam medicine, sweet, flat. Return spleen, lung, kidney channel. Invigorate the spleen and nourish the stomach, promote body fluid and benefit the lung, invigorate the kidney and astringent essence. Used for insufficiency of the spleen, lack of food, persistent diarrhea, dyspnea and cough due to lung deficiency, spermatorrhea due to kidney deficiency, leukorrhea, frequent urination, deficiency-heat and quenching thirst. Fried yam with bran nourishes the spleen and stomach. Used for insufficiency of the spleen, lack of food, loose stools, and excessive leucorrhea.
陈皮,苦、辛,温。归肺、脾经。理气健脾,燥湿化痰。用于胸脘胀满,食少吐泻,咳嗽痰多。Tangerine peel, bitter, pungent, warm. Return lung, spleen channel. Regulating qi and invigorating the spleen, drying dampness and resolving phlegm. It is used for fullness in the chest cavity, vomiting and diarrhea due to lack of food, and cough with excessive phlegm.
淫羊藿,辛、甘,温。归肝、肾经。补肾阳,强筋骨,祛风湿。用于阳痿遗精,筋骨痿软,风湿痹痛,麻木拘挛;更年期高血压。Epimedium, pungent, sweet, warm. Return liver, kidney channel. Tonify kidney yang, strengthen muscles and bones, and dispel rheumatism. For impotence and nocturnal emission, flaccidity of muscles and bones, rheumatic arthralgia, numbness and contracture; menopausal hypertension.
山楂,酸、甘、微温。归脾、胃、肝经。消食健胃,行气散瘀。用于肉食积滞,胃脘胀满,泻痢腹痛,瘀血经闭,产后瘀阻,心腹刺痛,疝气疼痛;高脂血症。焦山楂消食导滞作用增强。用于肉食积滞,泻痢不爽。Hawthorn, sour, sweet, slightly warm. Return spleen, stomach, liver channel. Dispelling food and invigorating the stomach, promoting qi and dispelling blood stasis. For stagnation of meat, fullness in the epigastric cavity, diarrhea and abdominal pain, amenorrhea due to blood stasis, postpartum stasis, tingling pain in trusted subordinates, hernia pain; hyperlipidemia. Jiao Hawthorn enhances digestion and guides stagnation. Used for stagnation of meat, diarrhea and dysentery.
黄芪,甘,温。归肺、脾经。补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴。Radix Astragali, sweet, warm. Return lung, spleen channel. Invigorating qi and solidifying the surface, diuretic to support toxin, evacuation of pus, astringing sores and promoting granulation. For qi deficiency and fatigue, lack of appetite, loose stools, subsidence of middle qi, chronic diarrhea and prolapse of the anus, blood in stool and metrorrhagia, spontaneous sweating due to surface deficiency, edema due to deficiency of qi, carbuncle and gangrene that are difficult to burst, long-term ulceration, blood deficiency, flaccidity and jaundice, internal heat and quenching thirst.
芡实,甘、涩,平。归脾、肾经。益肾固精,补脾止泻,祛湿止带。用于梦遗滑精,遗尿尿频,脾虚久泻,白浊,带下。Gorgon fruit, sweet, astringent, flat. Return spleen, kidney channel. Tonifying the kidney and strengthening essence, invigorating the spleen and arresting diarrhea, dispelling dampness and stopping leukorrhea. Used for nocturnal emission, enuresis, frequent urination, chronic diarrhea due to spleen deficiency, white turbidity, leukorrhea.
菟丝子,甘,温。归肝、肾、脾经。滋补肝肾,固精缩尿,安胎,明目,止泻。用于阳痿遗精,尿有余沥,遗尿尿频,腰膝酸软,目昏耳鸣,肾虚胎漏,胎动不安,脾肾虚泻。Semen Cuscuta, sweet, warm. Return liver, kidney, spleen channel. Nourishing liver and kidney, solidifying essence and reducing urination, preventing miscarriage, improving eyesight, and stopping diarrhea. For impotence and spermatorrhea, residual urination, enuresis, frequent urination, soreness of the waist and knees, dizziness and tinnitus, fetal leakage due to kidney deficiency, restless fetal movement, diarrhea due to deficiency of the spleen and kidney.
合欢花,甘,平。归心、肝经。解郁安神。用于心神不安,忧郁失眠。Flos Albiziae Julibrissin, sweet, flat. GUIXIN, Liver Channel. Relieve depression and soothe the nerves. For restlessness, depression and insomnia.
桔梗,苦、辛,平。归肺经。宣肺,利咽,祛痰,排脓。用于咳嗽痰多,胸闷不畅,咽痛,音哑,肺痈吐脓,疮疡脓成不溃。Bellflower, bitter, pungent, flat. Return lung meridian. Xuanfei, sore throat, expectorant, evacuation of pus. It is used for cough with excessive phlegm, uncomfortable chest, sore throat, hoarseness, pulmonary abscess with pus vomiting, sores and ulcers with pus that does not burst.
厌食症为常见病、多发病。基本病机为脾失健运、胃失受纳、脾胃失和。治当健脾益气、扶脾助运,本发明以调整胃肠功能,调整气机以使脾胃运化旺盛,气血生化有源。方中白术、淮山药共奏健脾益胃之功为君药;陈皮,理气健脾,淫羊藿,理气止痛、补肾助阳,温运脾阳,二者共为臣药;山楂消食积、化滞瘀,黄芪益气固表,芡实、菟丝子补脾止泻为佐药;合欢花、桔梗解郁宣肺为使药。总之,诸药合用,健脾助运,消食和中,全方共奏消食导滞,理气化湿之功,以健运脾胃为根本,调畅气机以补脾胃而又无滞胃之虑,能行滞气,且无伤正之忧,胃和则能受纳,脾健则可运化,脾健胃和则厌食可愈,达到了增进患者食欲,改善精神状态不佳、腹痛腹胀、大便异常等伴随症状,可从根本治愈脾胃气虚型厌食症。Anorexia is common disease, frequently-occurring disease. The basic pathogenesis is spleen dysfunction, stomach failure, and spleen-stomach disharmony. To invigorate the spleen and replenish qi, support the spleen and assist transportation, the present invention adjusts the gastrointestinal function, adjusts the mechanism of qi so that the spleen and stomach are transported and transformed vigorously, and the biochemistry of qi and blood is active. In the prescription, Atractylodes macrocephala and Chinese yam have the functions of invigorating the spleen and stomach, and they are the monarch drug; tangerine peel, regulating qi and invigorating the spleen, epimedium, regulating qi and relieving pain, tonifying the kidney and supporting yang, and warming the spleen and yang, both are ministerial drugs; hawthorn eliminates food accumulation , dissipate stagnation, astragalus nourishes qi and strengthens the surface, Gorgon fruit, dodder nourishes the spleen and relieves diarrhea as adjuvant drugs; Albizia julibrissin and Platycodon grandiflorum relieve stagnation and lungs are used as envoys. In a word, all kinds of medicines are combined to strengthen the spleen and help transportation, promote digestion and harmonize the middle. , can carry stagnant qi, and there is no worry about harming the body, the stomach can be tolerated, the spleen can be transported, and the spleen can be used to heal anorexia. Accompanying symptoms such as abnormal stool can fundamentally cure anorexia of spleen and stomach qi deficiency.
为解决其技术问题所采用的技术方案是所述治疗厌食的药物组合物,由下列重量份配比的药物原料组成:白术16-22份,淮山药13-21份,陈皮13-19份,淫羊藿11-15份,山楂8-16份,黄芪6-16份,芡实5-12份,菟丝子3-11份,合欢花3-6份,桔梗1-5份。The technical solution adopted to solve the technical problem is the pharmaceutical composition for treating anorexia, which consists of the following pharmaceutical raw materials in proportions by weight: 16-22 parts of Atractylodes Rhizoma Rhizome, 13-21 parts of Chinese yam, 13-19 parts of tangerine peel, 11-15 parts of Epimedium, 8-16 parts of Hawthorn, 6-16 parts of Astragalus, 5-12 parts of Gorgon, 3-11 parts of Cuscuta, 3-6 parts of Albizia Julibrissin, 1-5 parts of Bellflower.
本发明的优选技术方案是,所述本发明药物组合物由以下重量份的原料制得:白术19份,淮山药17份,陈皮16份,淫羊藿13份,山楂12份,黄芪11份,芡实9份,菟丝子7份,合欢花5份,桔梗3份。The preferred technical solution of the present invention is that the pharmaceutical composition of the present invention is prepared from the following raw materials in parts by weight: 19 parts of Atractylodes macrocephala, 17 parts of Chinese yam, 16 parts of tangerine peel, 13 parts of epimedium, 12 parts of hawthorn, and 11 parts of astragalus , 9 parts of Gorgon, 7 parts of Cuscuta, 5 parts of Albizia Julibrissin, and 3 parts of Campanulaceae.
本发明还提供了所述药物组合物的制备方法,具体包括如下步骤:The present invention also provides a preparation method of the pharmaceutical composition, specifically comprising the following steps:
将上述重量份的原料山楂,陈皮,淫羊藿,淮山药,黄芪,合欢花,芡实,白术,菟丝子,桔梗分别粉碎成粗粉,混合均匀,加总质量3倍量水煎煮2次,每次30min后过滤,加入滤液2倍量的醇浓度为75%的乙醇回流提取2次,每次60min,过滤,回收乙醇,将滤液浓缩至稠膏,即得。The raw materials hawthorn, tangerine peel, epimedium, Chinese yam, astragalus, albizia juniper, gorgon, Atractylodes macrocephala, dodder, and platycodon grandiflora are respectively crushed into coarse powder, mixed evenly, and decocted twice in water with 3 times the total mass. Filtrate after 30 minutes each time, add 2 times the amount of ethanol with an alcohol concentration of 75% to the filtrate, reflux extraction twice, 60 minutes each time, filter, recover ethanol, concentrate the filtrate to a thick paste, and obtain.
本领域技术人员可以在制得的本发明药物活性成分基础上直接入药服用或加入药剂学上可接受的辅料按常规工艺制备成所需制剂。如可以制成常用的片剂(分散片、泡腾片、口腔崩解片、含片、咀嚼片、泡腾片)、胶囊剂(硬胶囊、软胶囊剂)、颗粒剂、丸剂(滴丸剂)、散剂等固体制剂形式的口服药物,也可以制成糖浆、口服液、水剂、合剂、汤剂等液体制剂形式的口服药物。因此,该药物组合物中除有效成分外,还可以含有药学上可以接受的辅料。优选的是,本发明药物组合物按照常规制备工艺制备成口服液、糖浆、丸剂或散剂等。使用本发明药物组合物治疗厌食症时,服用所制备的糖浆或口服液,每次10mL药液,一日2次,每毫升糖浆或口服液含生药量0.3g;或者服用所制备的散剂,每袋含生药量6g,每次半袋,一日2次;或者服用所制备的丸剂,每丸含生药量1g,每次3粒,一日2次。Those skilled in the art can take the prepared pharmaceutical active ingredient of the present invention directly into medicine or add pharmaceutically acceptable adjuvants to prepare required preparations according to conventional techniques. For example, it can be made into commonly used tablets (dispersible tablets, effervescent tablets, orally disintegrating tablets, buccal tablets, chewable tablets, effervescent tablets), capsules (hard capsules, soft capsules), granules, pills (dropping pills) ), powders and other solid preparation forms can also be made into liquid preparation forms such as syrup, oral liquid, water, mixture and decoction. Therefore, besides the active ingredients, the pharmaceutical composition may also contain pharmaceutically acceptable auxiliary materials. Preferably, the pharmaceutical composition of the present invention is prepared into oral liquids, syrups, pills or powders, etc. according to conventional preparation techniques. When using the pharmaceutical composition of the present invention to treat anorexia, take the prepared syrup or oral liquid, each 10mL medicinal liquid, twice a day, every milliliter of syrup or oral liquid contains 0.3g of crude drug; or take the prepared powder, Each bag contains 6g of crude drug, half a bag each time, twice a day; or take the prepared pills, each pill contains 1g of crude drug, 3 capsules each time, twice a day.
本发明还请求保护上述药物组合物在制备治疗厌食特别是在制备治疗脾胃气虚型厌食药物中的用途。在通过本发明药物组合物的安全性评价后,选用临床病例观察可知所治疗的94例脾胃气虚型厌食患者,治疗过程中无脱落病例,均完成临床观察。两组患儿治疗2疗程后总疗效比较,治疗组治愈率为44.68%,对照组为8.51%,治愈率比较,P值均<0.05,有显著性差异;总有效率治疗组为97.87%,对照组为74.47%,总有效率比较,P值均<0.05,有显著差异。两组治疗前后尿常规、便常规、肝功、肾功、心电图无任何异常变化,无不良反应及对本药过敏者。结果表明治疗组治愈率及有效率明显优于对照组,有显著性差异。使用本发明所述药物组合物治疗厌食特别是治疗属于脾胃气虚型厌食疗效确切,安全可靠,可作为治疗脾胃气虚型厌食的有效方法,在临床中值得推广使用。同时治疗组随访1年无一例复发、治疗期间无不良反应。由此说明本发明药物组合物组方后达到了健脾和胃,消食导滞,理气化湿的目的,起到了标本兼治的显著效果。The present invention also claims the application of the above-mentioned pharmaceutical composition in the preparation of a medicine for treating anorexia, especially in the preparation of a medicine for treating spleen-stomach qi deficiency type anorexia. After passing the safety evaluation of the pharmaceutical composition of the present invention, clinical case observations were selected to show that 94 cases of anorexia patients with spleen-stomach deficiency type were treated, and there were no dropout cases during the treatment process, and the clinical observations were all completed. After 2 courses of treatment, the total curative effect of the two groups of children was compared. The cure rate of the treatment group was 44.68%, and that of the control group was 8.51%. The control group was 74.47%. Compared with the total effective rate, the P values were all <0.05, and there was a significant difference. There were no abnormal changes in urine routine, stool routine, liver function, kidney function, and electrocardiogram before and after treatment in the two groups, and there were no adverse reactions or allergies to the drug. The results showed that the cure rate and effective rate of the treatment group were significantly better than those of the control group, and there were significant differences. Using the pharmaceutical composition of the present invention to treat anorexia, especially anorexia of spleen-stomach-qi deficiency type, has definite curative effect, is safe and reliable, can be used as an effective method for treating spleen-stomach-qi-deficiency type anorexia, and is worthy of popularization and use in clinic. At the same time, the treatment group was followed up for 1 year without any recurrence and no adverse reaction during treatment. This shows that the pharmaceutical composition of the present invention has reached the purpose of invigorating the spleen and harmonizing the stomach, eliminating food stagnation, regulating qi and removing dampness, and has played a significant effect of treating both symptoms and root causes.
本发明药物组合物为天然纯中药制剂,原药易得、成本低廉,遵循中医的处方用药原则,不良反应和副作用显著降低,安全系数高,经临床应用验证,其疗效确切,药性平和,未出现毒副作用及严重不良反应,临床观察总有效率达到100%,可以较好地治疗厌食特别是脾胃气虚型厌食。同时本发明制备的药品用药方便,提高了厌食患者的用药依从性,提高了患者的生活质量。The pharmaceutical composition of the present invention is a natural pure Chinese medicine preparation, the original medicine is easy to obtain, and the cost is low. It follows the prescription and medication principles of traditional Chinese medicine, significantly reduces adverse reactions and side effects, and has a high safety factor. It has been verified by clinical application. Toxic side effects and severe adverse reactions occur, and the total effective rate of clinical observation reaches 100%, which can better treat anorexia, especially anorexia of spleen-stomach deficiency type. Simultaneously, the medicine prepared by the invention is convenient for administration, improves the medication compliance of the anorexia patient, and improves the life quality of the patient.
具体实施方式detailed description
以下通过具体实施例进一步描述本发明,但是本发明不仅仅限于以下具体实施例。在本发明的范围内或者在不脱离本发明的内容、精神和范围内,对本发明进行的变更、组合或替换,对于本领域的技术人员来说是显而易见的,且包含在本发明的范围之内。The present invention is further described below through specific examples, but the present invention is not limited to the following specific examples. Within the scope of the present invention or without departing from the content, spirit and scope of the present invention, changes, combinations or substitutions to the present invention are obvious to those skilled in the art and are included in the scope of the present invention Inside.
实施例1Example 1
按以下重量份称取本发明各原料:白术19份,淮山药17份,陈皮16份,淫羊藿13份,山楂12份,黄芪11份,芡实9份,菟丝子7份,合欢花5份,桔梗3份。Weigh each raw material of the present invention according to the following parts by weight: 19 parts of Atractylodes macrocephala, 17 parts of Chinese yam, 16 parts of tangerine peel, 13 parts of epimedium, 12 parts of hawthorn, 11 parts of astragalus, 9 parts of gorgon, 7 parts of dodder, 5 parts of Albizia juniper , 3 parts bellflower.
制备工艺:将上述重量份的原料山楂、陈皮、淫羊藿、淮山药、黄芪、合欢花、芡实、白术、菟丝子和桔梗分别粉碎成粗粉,混合均匀,加总质量3倍量水煎煮2次,每次30min后过滤,加入滤液2倍量的醇浓度为75%的乙醇回流提取2次,每次60min,过滤,回收乙醇,将滤液浓缩至稠膏。本领域技术人员可以在制得的本发明药物活性成分基础上直接入药服用或加入药剂学上可接受的辅料按常规工艺制得口服液、糖浆、丸剂或散剂等常用的口服制剂。Preparation process: Grind the raw materials hawthorn, tangerine peel, epimedium, Chinese yam, astragalus, albizia juniper, gorgon, atractylodes macrocephala, dodder and platycodon root into coarse powder, mix evenly, and decoct in 3 times the total mass Twice, filter after 30 minutes each time, add 2 times the amount of ethanol with an alcohol concentration of 75% to the filtrate for reflux extraction twice, 60 minutes each time, filter, recover ethanol, and concentrate the filtrate to a thick paste. Those skilled in the art can make oral liquids, syrups, pills or powders and other commonly used oral preparations on the basis of the prepared pharmaceutical active ingredients of the present invention and take them directly or add pharmaceutically acceptable adjuvants according to conventional techniques.
使用本发明药物组合物治疗厌食症时,服用所制备的糖浆或口服液,每次10mL药液,一日2次,每毫升糖浆或口服液含生药量0.3g;或者服用所制备的散剂,每袋含生药量6g,每次3g,一日2次;或者服用所制备的丸剂,每丸含生药量1g,每次3丸,一日2次。When using the pharmaceutical composition of the present invention to treat anorexia, take the prepared syrup or oral liquid, each 10mL medicinal liquid, twice a day, every milliliter of syrup or oral liquid contains 0.3g of crude drug; or take the prepared powder, Each bag contains 6g of crude drug, 3g each time, twice a day; or take the prepared pills, each pill contains 1g of crude drug, 3 pills each time, twice a day.
实施例2Example 2
按以下重量份称取本发明各原料:白术16份,淮山药13份,陈皮13份,淫羊藿11份,山楂8份,黄芪6份,芡实5份,菟丝子3份,合欢花3份,桔梗1份。Weigh each raw material of the present invention according to the following parts by weight: 16 parts of Atractylodes macrocephala, 13 parts of Chinese yam, 13 parts of tangerine peel, 11 parts of epimedium, 8 parts of hawthorn, 6 parts of astragalus, 5 parts of gorgon, 3 parts of dodder, and 3 parts of albizia , 1 serving of bellflower.
实施例3Example 3
按以下重量份称取本发明各原料:白术22份,淮山药21份,陈皮19份,淫羊藿15份,山楂16份,黄芪16份,芡实12份,菟丝子11份,合欢花6份,桔梗5份。Weigh each raw material of the present invention according to the following parts by weight: 22 parts of Atractylodes macrocephala, 21 parts of Chinese yam, 19 parts of tangerine peel, 15 parts of epimedium, 16 parts of hawthorn, 16 parts of astragalus, 12 parts of Gorgon fruit, 11 parts of dodder seed, 6 parts of Albizia julibrissin , bellflower 5 parts.
实施例4Example 4
按以下重量份称取本发明各原料:白术16份,淮山药21份,陈皮13份,淫羊藿15份,山楂8份,黄芪16份,芡实5份,菟丝子11份,合欢花3份,桔梗5份。Weigh each raw material of the present invention according to the following parts by weight: 16 parts of Atractylodes macrocephala, 21 parts of Chinese yam, 13 parts of tangerine peel, 15 parts of epimedium, 8 parts of hawthorn, 16 parts of astragalus, 5 parts of gorgon, 11 parts of dodder, 3 parts of Albizia julibrissin , bellflower 5 parts.
实施例5Example 5
按以下重量份称取本发明各原料:白术22份,淮山药13份,陈皮19份,淫羊藿11份,山楂16份,黄芪6份,芡实12份,菟丝子3份,合欢花6份,桔梗1份。Weigh each raw material of the present invention according to the following parts by weight: 22 parts of Atractylodes macrocephala, 13 parts of Chinese yam, 19 parts of tangerine peel, 11 parts of epimedium, 16 parts of hawthorn, 6 parts of astragalus, 12 parts of gorgon, 3 parts of dodder, 6 parts of Albizia julibrissin , 1 serving of bellflower.
实施例2-5的制备工艺同实施例1。The preparation process of embodiment 2-5 is the same as embodiment 1.
实施例6本发明药物组合物治疗厌食症的临床观察The clinical observation of embodiment 6 pharmaceutical composition of the present invention treats anorexia
1、病例资料:选择医院儿科病房及门诊就诊的符合纳入标准的厌食(脾胃气虚型)患儿94例。采用随机分组、平行对照的方法进行研究。1. Case data: 94 children with anorexia (spleen-stomach qi deficiency) who met the inclusion criteria were selected from the pediatric ward and outpatient clinic of the hospital. The research was carried out by random grouping and parallel control method.
所纳入观察对象中,治疗组:47例,其中男24例,女23例,年龄2-14岁,病程2-12个月,轻度0例、中度30例、重度17例。对照组:47例,其中男22例,女25例,年龄2-14岁,病程2-12个月,轻度0例、中度29例、重度18例。两组性别、年龄、病程、病情等经统计学处理经统计学处理,比较无显著性差异(P>0.05),具有可比性。Among the observed objects, the treatment group: 47 cases, including 24 males and 23 females, aged 2-14 years, with a course of 2-12 months, 0 mild cases, 30 moderate cases, and 17 severe cases. Control group: 47 cases, including 22 males and 25 females, aged 2-14 years, with a course of 2-12 months, 0 mild cases, 29 moderate cases, and 18 severe cases. There was no significant difference between the two groups in terms of gender, age, course of disease, and illness after statistical processing (P>0.05), which was comparable.
2、诊断依据:2. Diagnosis basis:
1)西医诊断标准:1) Western medicine diagnostic criteria:
(1)长期食欲不振,见食不贪,食量较病前减少1/3-1/2以上,排除其他系统疾病;(1) Long-term loss of appetite, not greedy when seeing food, food intake reduced by more than 1/3-1/2 compared with before the disease, excluding other systemic diseases;
(2)体重增长停滞或减缓,有不良饮食习惯或喂养不当史。(2) Stagnated or slowed weight gain, poor eating habits or a history of improper feeding.
2)中医诊断标准:2) TCM diagnostic criteria:
(1)长期食欲不振,而无其他疾病者。(1) Long-term loss of appetite without other diseases.
(2)面色少华,形体偏瘦,但精神尚好,无腹膨。(2) Shaohua complexion, thin body, but good spirit, no abdominal distension.
(3)有喂养不当史,如进食无定时定量、过食生冷、甘甜厚味、零食或偏食等。(3) There is a history of improper feeding, such as eating without a fixed amount, overeating raw or cold, sweet and savory, snacks or partial eclipse, etc.
3)中医证候诊断标准:脾胃气虚型3) TCM syndrome diagnostic criteria: spleen and stomach qi deficiency
主证:食欲减退,食量减少。Main symptoms: loss of appetite, decreased food intake.
次证:①面色萎黄,形体消瘦;Secondary symptoms: ① Pale complexion and emaciated body;
②神疲懒言,体倦乏力,肌肉松软;② Mental fatigue and lazy speech, body fatigue and weakness, muscle weakness;
③大便不成形或夹不消化食物;③The stool is deformed or cannot digest food;
④容易出汗;④ easy to sweat;
⑤食后腹胀;⑤ abdominal distension after eating;
⑥舌质淡,苔薄白;⑥Pale tongue with thin white fur;
⑦脉无力或指纹紫滞,现于风关。⑦ Weak pulse or purple stagnation of fingerprints, present in Fengguan.
4)症状体征分级量化标准:小儿厌食症症状分级标准:参照国家药品监督管理局颁布的《中药新药临床研究指导原则》(试行)中的小儿厌食症评级法拟订。4) Quantitative standard for the grading of symptoms and signs: the grading standard for anorexia symptoms in children: it was formulated with reference to the grading method for anorexia in children in the "Guiding Principles for Clinical Research of New Chinese Medicines" (Trial) promulgated by the State Drug Administration.
小儿厌食症主要症状分级量化表Grading scale for main symptoms of anorexia in children
小儿厌食次要症状分级量化表Anorexia Secondary Symptom Grading and Quantification Scale
3、纳入标准:3. Inclusion criteria:
(1)符合本病诊断标准者;(1) Those who meet the diagnostic criteria of this disease;
(2)符合本病中医证候标准中的脾胃气虚证者;(2) Those who meet the spleen-stomach qi deficiency syndrome in the TCM syndrome standard of this disease;
(3)年龄2-14岁,性别不限;(3) Age 2-14 years old, gender is not limited;
(4)试验前1周内未使用过消食导滞药及助消化药;(4) Did not use digestion-inducing drugs and digestive-aiding drugs within 1 week before the test;
(5)受试者监护人签署知情同意书者。(5) The subject's guardian signed the informed consent form.
4、排除标准:4. Exclusion criteria:
(1)合并有心血管、脑血管、肝、肾和造血系统等原发性疾病,精神病患者;(1) Combined with primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, mentally ill;
(2)未能排除其他系统疾病所致厌食者;(2) Anorexia caused by other systemic diseases cannot be ruled out;
(3)已知或可能对试验药物及其组分过敏者。(3) Those who are known or may be allergic to the test drug and its components.
5、剔除和脱落标准:5. Rejection and shedding standards:
(1)病例入选后,发现不符合纳入标准或符合排除标准者;(1) After the case is selected, it is found that those who do not meet the inclusion criteria or meet the exclusion criteria;
(2)出现严重不良事件,根据医生判断应停止该病例临床试验者;(2) Serious adverse events occur, and the clinical trial of this case should be stopped according to the doctor's judgment;
(3)病例入选后资料不全或未按规定用药者,而影响疗效或安全性判断者。(3) Cases with incomplete data or not prescribed medication after case selection, which will affect the judgment of curative effect or safety.
6、用法用量:6. Usage and dosage:
治疗组:取实施例5制备的口服液,每次服用10mL药液,一日2次,每毫升糖浆含生药量0.3g。Treatment group: take the oral liquid prepared in Example 5, take 10 mL of liquid medicine each time, twice a day, and every milliliter of syrup contains 0.3 g of crude drug.
对照组:健儿素冲剂(国药准字Z42020712,10g*12袋),开水冲服,2-5岁每次10g,每日3次;6-14岁每次15g,每日3次。Control group: Jianersu Granules (Z42020712, 10g*12 bags), boiled water, 10g each time for 2-5 years old, 3 times a day; 15g each time for 6-14 years old, 3 times a day.
14天为1疗程,两组均连用2疗程。14 days was a course of treatment, and both groups were given 2 courses of treatment.
7、疗效评定:7. Efficacy evaluation:
(1)痊愈:症状完全解除,食欲与食量恢复到正常水平,症状积分下降率大于或等于95%;(1) Recovery: Symptoms are completely relieved, appetite and food intake return to normal levels, and the decline rate of symptom scores is greater than or equal to 95%;
(2)显效:症状基本解除,食欲明显好转,食量恢复到原有水平的3/4,症状积分下降率大于或等于70%;(2) Significantly effective: the symptoms are basically relieved, the appetite is obviously improved, the food intake is restored to 3/4 of the original level, and the symptom score reduction rate is greater than or equal to 70%;
(3)有效:食欲有改善,食量有所恢复,但未达到原有水平的3/4,症状积分下降率大于或等于30%;(3) Effective: the appetite has improved, the food intake has recovered, but it has not reached 3/4 of the original level, and the decline rate of symptom scores is greater than or equal to 30%;
(4)无效:食欲及食量均未见明显改善或有所加重,症状积分下降率小于30%。(4) Ineffective: appetite and food intake were not significantly improved or aggravated, and the decrease rate of symptom scores was less than 30%.
8、治疗效果:8. Treatment effect:
治疗过程中无脱落病例,均完成临床观察。两组患儿治疗2疗程后总疗效比较,治疗组治愈率为44.68%,对照组为8.51%,治愈率比较,P值均<0.05,有显著性差异;总有效率治疗组为97.87%,对照组为74.47%,总有效率比较,P值均<0.05,有显著差异。两组治疗前后尿常规、便常规、肝功、肾功、心电图无任何异常变化,无不良反应及对本药过敏者。结果表明治疗组治愈率及有效率明显优于对照组,有显著性差异。使用本发明所述药物组合物治疗厌食特别是治疗属于脾胃气虚型厌食疗效确切,安全可靠,可作为治疗脾胃气虚型厌食的有效方法,在临床中值得推广使用。During the course of treatment, there were no drop-out cases, and clinical observation was completed. After 2 courses of treatment, the total curative effect of the two groups of children was compared. The cure rate of the treatment group was 44.68%, and that of the control group was 8.51%. The control group was 74.47%. Compared with the total effective rate, the P values were all <0.05, and there was a significant difference. There were no abnormal changes in urine routine, stool routine, liver function, kidney function, and electrocardiogram before and after treatment in the two groups, and there were no adverse reactions or allergies to the drug. The results showed that the cure rate and effective rate of the treatment group were significantly better than those of the control group, and there were significant differences. Using the pharmaceutical composition of the present invention to treat anorexia, especially anorexia of spleen-stomach-qi deficiency type, has definite curative effect, is safe and reliable, can be used as an effective method for treating spleen-stomach-qi-deficiency type anorexia, and is worthy of popularization and use in clinic.
治疗组和对照组的疗效比较Comparison of curative effect between treatment group and control group
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410728850.3A CN104474202B (en) | 2014-12-04 | 2014-12-04 | A kind of pharmaceutical composition for the treatment of anorexia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410728850.3A CN104474202B (en) | 2014-12-04 | 2014-12-04 | A kind of pharmaceutical composition for the treatment of anorexia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104474202A CN104474202A (en) | 2015-04-01 |
CN104474202B true CN104474202B (en) | 2016-02-17 |
Family
ID=52748903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410728850.3A Expired - Fee Related CN104474202B (en) | 2014-12-04 | 2014-12-04 | A kind of pharmaceutical composition for the treatment of anorexia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104474202B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105748826A (en) * | 2016-04-08 | 2016-07-13 | 北京御心堂生物科技股份有限公司 | Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof |
CN106110084A (en) * | 2016-08-31 | 2016-11-16 | 瑞普(天津)生物药业有限公司 | A kind of Chinese medicine composition for treating pet dog anorexia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822764A (en) * | 2010-01-18 | 2010-09-08 | 郑延明 | External patch for treating children anorexia and preparation method thereof |
CN103341115A (en) * | 2013-07-16 | 2013-10-09 | 冯宇伟 | Medicine for treating spleen-stomach deficiency of children and preparation method thereof |
-
2014
- 2014-12-04 CN CN201410728850.3A patent/CN104474202B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104474202A (en) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101766774B (en) | Chinese medicine composite for treating duodenal ulcer and preparation method thereof | |
CN101693102A (en) | Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof | |
CN103536742B (en) | A kind ofly treat pharmaceutical composition of chronic enterogastritis disease and preparation method thereof | |
CN104474202B (en) | A kind of pharmaceutical composition for the treatment of anorexia | |
CN104547502A (en) | Traditional Chinese medicine composition for treating sicca syndrome | |
CN102988851A (en) | Chinese medicine composition for treating hemoptysis and preparation method of Chinese medicine composition | |
CN103638234B (en) | A kind of Chinese medicine composition, preparation and preparation method thereof for the treatment of tinnitus | |
CN103301353B (en) | Pharmaceutical composition for treating atrophic vaginitis | |
CN115845009B (en) | Umbilical moxibustion medicinal powder for treating spleen deficiency and diarrhea and its application | |
CN115252753B (en) | Traditional Chinese medicine composition for treating insomnia and application thereof | |
CN103330837B (en) | A traditional Chinese medicine composition for treating postmenopausal women's osteoporosis | |
CN117599125A (en) | A Chinese medicinal composition for supplementing calcium and strengthening bones for treating osteoporosis, and its preparation method and application | |
CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
CN100455319C (en) | A traditional Chinese medicine preparation for treating cough in children and its preparation method | |
CN103990009A (en) | Traditional Chinese medicine for treatment of type II diabetes by invigorating spleen and purging turbidness | |
CN114832079A (en) | Traditional Chinese medicine composition for treating functional abdominal distension and preparation method thereof | |
CN103908616B (en) | The medicament of tumor remission patient radiotherapy side effect and preparation method | |
CN103330867B (en) | Preparation method of powder for treating senile vaginitis | |
CN102885946A (en) | Chinese medicament for treating cough and asthma | |
CN116999517B (en) | A Chinese medicine composition and its use | |
CN116549595B (en) | Pharmaceutical composition for treating functional dyspepsia of children, preparation and application thereof | |
CN105311602B (en) | A kind of Chinese medicine composition of prevention asthma in children | |
CN104225016A (en) | Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis | |
CN117159658B (en) | A Chinese medicinal composition for preventing, relieving or treating intractable insomnia, and its preparation method | |
CN108815226A (en) | A kind of gynemetrics's drug and preparation method thereof for treating endocrine disorder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Fengyue Inventor after: Ren Jifeng Inventor after: Tan Honglei Inventor before: Liu Qingxiang |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160113 Address after: 266000 No. four, No. 127 South Road, Shandong, Qingdao Applicant after: Zhongxin Hospital, Qingdao Address before: Qin village 277799 Shandong city of Linyi province Lanling County No. 149 Bian Zhen Applicant before: Zou Shidong |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160217 Termination date: 20161204 |